Kaplan Fox & Kilsheimer LLP Encourages Gildan Activewear Inc. (NYSE: GIL) Investors to Contact the Firm Before December 14, 2026

A class action lawsuit alleges Gildan made false or misleading statements and used channel stuffing to create an appearance of revenue during February 19, 2025–June 15, 2026. The allegations cite a June 16, 2026 report by short seller Jehoshaphat Research, which claimed Gildan had pulled forward around $500 million of revenue; Gildan shares fell $11.63, or 18.7%, that day to $50.34. The claims are allegations, and investors may seek lead-plaintiff status by December 14, 2026.

Analysis

The lawsuit is a low-information legal catalyst, not independent confirmation of the short seller’s accounting allegations. The investable issue is whether reported growth converted to cash: if receivables have outgrown sales or collections weaken, the market may discount not only near-term revenue but also the reliability of guidance and the multiple investors will pay for it. Conversely, the prior sharp repricing raises the bar for a fresh short; the complaint itself does not establish liability or prove that revenue was improperly recognized.

Over the next 1–3 months, focus on Gildan’s reported receivables, days sales outstanding, operating cash conversion, returns/allowances, and any explanation of distributor inventory or subsequent-quarter shipments. Evidence of collection deterioration, elevated channel inventory, or guidance pressure would support a further de-rating and could force customers to reduce orders—potentially benefiting competing apparel suppliers only if demand is retained rather than deferred. Over 6–18 months, a sustained control or disclosure overhang could raise financing and governance risk premiums, even absent a court finding. Key reversal risks are timely collections, normalizing working capital, and auditor- or company-provided evidence that rebuts the channel-stuffing thesis. The December 14 lead-plaintiff deadline is procedural; do not treat it as an operating catalyst.

Key Decisions for Investors

• Do not initiate or add to a GIL short solely on the class-action announcement. Treat the core allegations as unverified and monitor the next filing/earnings release for receivables growth versus sales, cash conversion, returns and distributor inventory disclosures.
• For existing exposure, keep risk defined: consider a limited-premium GIL put position only if operating data corroborate deterioration; avoid an uncapped short after the large prior repricing. No price target is warranted from the supplied information.
• Set a thesis trigger: strengthen the bearish view on weaker collections, worsening DSO, rising allowances/returns, or a guidance reduction; reduce it if receivables normalize and cash conversion supports reported sales. Verify the underlying periods and business scope before comparing metrics.
• Watch for customer destocking as a second-order risk to Gildan’s subsequent shipments, while avoiding an automatic long in competitors such as Hanesbrands: lost Gildan orders may reflect delayed category demand rather than supplier substitution.